Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 5/2008

01-05-2008 | Original Research Article

Inhaled Corticosteroids and the Risk of Fractures in Older Adults

A Systematic Review and Meta-Analysis

Authors: Dr Mahyar Etminan, Mohsen Sadatsafavi, Saeedreza Ganjizadeh Zavareh, Bahi Takkouche, J. Mark FitzGerald

Published in: Drug Safety | Issue 5/2008

Login to get access

Abstract

Background: Inhaled corticosteroids (ICS) are commonly prescribed medications for the management of asthma and chronic obstructive pulmonary disease. It is well established that long-term use of these drugs may lower bone mineral density. However, whether ICS increase the risk of fractures remains unknown. Recent studies that have attempted to explore this risk have had conflicting results. We sought to explore the risk of ICS and fractures among older adults by conducting a systematic review and meta-analysis of the literature.
Methods: We systematically searched several databases, including MEDLINE, EMBASE and the Cochrane Library, to identify pertinent studies.Those studies that potentially met our inclusion criteria were identified by two reviewers. Relative risks (RRs) were pooled using the random effects model. We also explored dose-response by stratifying the analysis on high and low doses of ICS. Heterogeneity was assessed using the Q statistic and publication bias was assessed using the funnel plot.
Results: Thirteen studies, including four randomized controlled trials, were included in the review. The pooled RRs for hip fractures and any fractures were 0.91 (95% CI 0.87, 0.96) and 1.02 (95% CI 0.96, 1.08), respectively. When we restricted the analysis to users of high-dose ICS, the pooled RRs for any fractures and hip fractures were 1.30 (95% CI 1.07, 1.58) and 1.32 (95% CI 0.90, 1.92), respectively. The funnel plot did not show evidence of publication bias.
Conclusion: We found no association between the use of ICS and fractures in older adults. A slight increase in risk was seen in those using high-dose ICS. The significance of this association should be investigated further.
Literature
1.
Viegi G, Scognamiglio S, Baldacci F, et al. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001; 68: 4–19PubMedCrossRef
2.
Buckley NS, Salopeter SR. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clin Rev Allergy Immunol 2006; 31: 210–30
3.
Motimer KJ, Harrison TW, Tattersfield AE. Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol 2005; 94: 15–21CrossRef
4.
Johnell O, Pauwels R, Lofdahl CG, et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J 2002; 19: 1058–63PubMedCrossRef
5.
Hubbard RB, Smith CJ, Smeeth L, et al. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002; 166: 1563–6PubMedCrossRef
6.
Lee TA, Weiss KB. Fracture risk associated with inhaled corti-costeroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 855–9PubMedCrossRef
7.
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–89PubMedCrossRef
8.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000 19; 283(15): 2008–12PubMedCrossRef
9.
Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354(9193): 1896–900PubMedCrossRef
10.
Scanlon PD, Connett JE, Wise RA, et al. Lung Health Study Research Group. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 2004; 170: 1302–9PubMedCrossRef
11.
Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340: 1948–53PubMedCrossRef
12.
Suissa S, Baltzan M, Kremer R, et al. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169: 83–8PubMedCrossRef
13.
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med 2005; 257: 374–84PubMedCrossRef
14.
Johannes CB, Schneider GA, Dube TJ, et al. The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease. Chest 2005; 127: 89–97PubMedCrossRef
15.
de Vries F, Pouwels S, Lammers JW, et al. Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med 2007; 261: 170–7PubMed
16.
de Vries F, van Staa TP, Bracke MS, et al. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005; 25: 879–84PubMedCrossRef
17.
Baltzan MA, Suissa S, Bauer DC, et al. Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. Lancet 1999; 353: 1327PubMedCrossRef
18.
Lau E, Mamdani M, Tu K. Inhaled or systemic corticosteroids and the risk of hospitalization for hip fracture among elderly women. Am J Med 2003; 114: 142–5PubMedCrossRef
19.
Hubbard R, Tattersfield A, Smith C, et al. Use of inhaled corticosteroids and the risk of fracture. Chest 2006; 130: 1082–8PubMedCrossRef
20.
Costa-Bouzas J, Takkouche B, Cadarso-Suarez C, et al. HEpiMA: software for the identification of heterogeneity in meta-analysis. Comput Methods Programs Biomed 2001; 64: 101–7PubMedCrossRef
21.
van Staa TP, Leufkens HG, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 2001; 16: 581–8PubMedCrossRef
22.
Fletcher AE, Jones DJ, Bulpitt CJ, et al. The MRC trial of assessment and management of older people in the community: objectives, design and interventions. BMC Health Services Res 2002; 2(1): 1–10CrossRef
23.
Tomlinson JE, McMashon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282–7PubMedCrossRef
24.
Van Staa TP, Leufkens B, Cooper C. Bone loss and inhaled gluccorticoids [letter]. New Engl J Med 2002; 346: 533PubMedCrossRef
Metadata
Title
Inhaled Corticosteroids and the Risk of Fractures in Older Adults
A Systematic Review and Meta-Analysis
Authors
Dr Mahyar Etminan
Mohsen Sadatsafavi
Saeedreza Ganjizadeh Zavareh
Bahi Takkouche
J. Mark FitzGerald
Publication date
01-05-2008
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 5/2008
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200831050-00005

Other articles of this Issue 5/2008

Drug Safety 5/2008 Go to the issue

Correspondence

TNF-α Inhibitors and Leukaemia: International Pharmacovigilance Reports

Conference Paper

European Legislation on Herbal Medicines

Original Research Article

Use of Statins and the Risk of Parkinson’s Disease

Conference Paper

Phytotherapic Compounds

Review Article

Drug-Induced Urinary Retention

Conference Paper

Assessment of the Risk of Fragrance Allergy in the General Population